John J. Sperzel III
CIK: 0001602618
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
John J. Sperzel III files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by John J. Sperzel III since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Sperzel John J III
Sperzel John J III (SEC CIK 0001602618) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Sperzel John J III, a Form 4, filed on Jan 2, 2025. Those filings report 2 transactions, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Sperzel John J III's filings is in LEXINGTON, MA.
Recent filings by Sperzel John J III
- Nov 4, 2024: Grants or awards of TTOO derivative securities (2 lines, Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director